# Daily Aspirin Treatment After Preeclampsia

> **NCT06168461** · EARLY_PHASE1 · RECRUITING · sponsor: **Anna Stanhewicz, PhD** · enrollment: 40 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06168461
- **Lead sponsor:** Anna Stanhewicz, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06168461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06168461, "Daily Aspirin Treatment After Preeclampsia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06168461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*